BHVN has 36-month beta value of 3.93. Analysts have mixed views on the stock, with 10 analysts rating it as a “buy,” 5 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BHVN is 88.59M, and currently, short sellers hold a 10.53% ratio of that float. The average trading volume of BHVN on January 10, 2025 was 899.53K shares.
BHVN) stock’s latest price update
Biohaven Ltd (NYSE: BHVN)’s stock price has plunge by -3.42relation to previous closing price of 39.17. Nevertheless, the company has seen a 1.48% surge in its stock price over the last five trading sessions. prnewswire.com reported 2025-01-07 that NEW HAVEN, Conn., Jan. 7, 2025 /PRNewswire/ — Biohaven Ltd.
BHVN’s Market Performance
Biohaven Ltd (BHVN) has experienced a 1.48% rise in stock performance for the past week, with a -12.53% drop in the past month, and a -26.21% drop in the past quarter. The volatility ratio for the week is 5.15%, and the volatility levels for the past 30 days are at 6.28% for BHVN. The simple moving average for the last 20 days is -0.31% for BHVN stock, with a simple moving average of -9.57% for the last 200 days.
Analysts’ Opinion of BHVN
Many brokerage firms have already submitted their reports for BHVN stocks, with Jefferies repeating the rating for BHVN by listing it as a “Buy.” The predicted price for BHVN in the upcoming period, according to Jefferies is $57 based on the research report published on September 16, 2024 of the previous year 2024.
Bernstein, on the other hand, stated in their research note that they expect to see BHVN reach a price target of $55. The rating they have provided for BHVN stocks is “Outperform” according to the report published on September 04th, 2024.
Morgan Stanley gave a rating of “Overweight” to BHVN, setting the target price at $58 in the report published on July 24th of the previous year.
BHVN Trading at -13.65% from the 50-Day Moving Average
After a stumble in the market that brought BHVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.19% of loss for the given period.
Volatility was left at 6.28%, however, over the last 30 days, the volatility rate increased by 5.15%, as shares sank -9.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.78% lower at present.
During the last 5 trading sessions, BHVN rose by +3.03%, which changed the moving average for the period of 200-days by -30.45% in comparison to the 20-day moving average, which settled at $37.98. In addition, Biohaven Ltd saw 1.29% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BHVN starting from CHILDS JOHN W, who purchase 29,000 shares at the price of $35.94 back on Dec 30 ’24. After this action, CHILDS JOHN W now owns 2,368,741 shares of Biohaven Ltd, valued at $1,042,393 using the latest closing price.
CHILDS JOHN W, the Director of Biohaven Ltd, purchase 21,052 shares at $47.50 during a trade that took place back on Oct 02 ’24, which means that CHILDS JOHN W is holding 21,052 shares at $999,970 based on the most recent closing price.
Stock Fundamentals for BHVN
The total capital return value is set at -2.37. Equity return is now at value -265.45, with -180.09 for asset returns.
Currently, EBITDA for the company is -429.14 million with net debt to EBITDA at 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.89.
Conclusion
To put it simply, Biohaven Ltd (BHVN) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
